Discover how AI is revolutionizing RNA drug development in a new article published in Engineering. Learn about the potential ...
Explore how Insilico collaborates with Servier to advance AI-driven drug discovery in oncology for unmet medical needs.
Insilico Medicine (“Insilico”), a world-leading artificial intelligence (AI)-driven drug discovery company, today announced a ...
Zhongyao Ma, PhD, holds a bachelor’s degree in biology from Shanghai Jiao Tong University and a PhD in genetics and developmental biology from the University of Georgia, U.S. His research focused on ...
Headlamp Health has launched Lumos AI®, a new decision-support platform designed to bring greater precision to neuroscience ...
News-Medical.Net on MSN
OutSee completes seed funding round and establishes partnership with o2h discovery for lead drug target candidate
OutSee, a genomics and drug discovery company pioneering a unique AI-based predictive genomics approach to target discovery, today announced the closure of its £2.5 M seed funding round.
Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback